AB0024 Systemic inflammation and b-cells in rheumatoid arthritis

Background Rheumatoid arthritis (RA) is heterogeneous in clinical symptoms, clinical parameters, pathogenesis and gene expression levels. Previously, we demonstrated variation in B-cell related gene expression between RA patients. Objectives The aim was to explore the relation of B-cell related gene...

Full description

Saved in:
Bibliographic Details
Published inAnnals of the rheumatic diseases Vol. 72; no. Suppl 3; p. A793
Main Authors Blits, M., Lubbers, J., Vosslamber, S., de Ridder, S., Wolbink, G.-J., van Schaardenburg, D., Nurmohamed, M., Pegtel, M., Verweij, C.
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group Ltd and European League Against Rheumatism 01.06.2013
BMJ Publishing Group LTD
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Rheumatoid arthritis (RA) is heterogeneous in clinical symptoms, clinical parameters, pathogenesis and gene expression levels. Previously, we demonstrated variation in B-cell related gene expression between RA patients. Objectives The aim was to explore the relation of B-cell related gene expression to clinical parameters of disease severity in early arthritis (EA) and established RA (esRA). Methods B-cell related gene expression (B-cell score) was determined in peripheral blood cells of 26 EA and 180 esRA patients, using multiplex real-time PCR. For the EA cohort, B-cell counts were also measured using flow cytometry. The esRA cohort was (randomly) divided into test and validation group of each 90 RA patients, with a mean DAS28 of 5.0 and 5.2, respectively. Associations were assessed between B-cell scores and the clinical disease parameters DAS28, CRP, RF, anti-CCP, nodules and erosions in all cohorts and B-cell counts only in EA cohort. Statistical testing was executed according to a bootstrap method which randomizes the esRA group a 1000 times into two equally sized groups. Results We demonstrated that the B-cell score reflected the peripheral blood B-cell count (p<0.0001, r=0.7463). In EA, the B-cell score revealed a significant negative correlation with CRP levels (p=0.0137; r=-0.4773). In the esRA group we also observed a negative correlation between the B-cell score and CRP levels (p=0.0004, r=-0.3666). This result was confirmed in the independent validationgroup (p=0.0194; r=-0.2461). Additionally, we performed a randomization with the bootstrap method, which showed the same significant correlations in almost all cases. However, no correlations were found between B-cell score and DAS28, RF, anti-CCP, nodules or erosions. Conclusions The B-cell score reflects the B-cell count in RA and a low B-cell count is associated with an increased marker of systemic inflammation in RA. Disclosure of Interest None Declared
Bibliography:ark:/67375/NVC-H3S4KCSG-L
href:annrheumdis-72-A793-1.pdf
ArticleID:annrheumdis-2013-eular.2347
local:annrheumdis;72/Suppl_3/A793-a
istex:C1D0B5F2C53F32607C68067783D6C1E7ED1E266D
ISSN:0003-4967
1468-2060
DOI:10.1136/annrheumdis-2013-eular.2347